MARKET

COEP

COEP

Coeptis Therapeutics Inc
NASDAQ
9.81
+0.22
+2.29%
After Hours: 8.75 -1.06 -10.81% 19:56 05/16 EDT
OPEN
9.34
PREV CLOSE
9.59
HIGH
10.00
LOW
9.34
VOLUME
16.41K
TURNOVER
--
52 WEEK HIGH
13.70
52 WEEK LOW
2.310
MARKET CAP
34.47M
P/E (TTM)
-1.9239
1D
5D
1M
3M
1Y
5Y
1D
NUBURU Advances $100M Capital Raise And Strategic Acquisition Of Defense & Security Hub Pending Italian 'Golden Power' Approval, Aiming To Drive Over $50M In 2025 Revenue While Relaunching Blue Laser Business
Benzinga · 5d ago
Weekly Report: what happened at COEP last week (0505-0509)?
Weekly Report · 5d ago
Weekly Report: what happened at COEP last week (0428-0502)?
Weekly Report · 05/05 09:59
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 04/30 17:05
Coeptis Therapeutics Holdings Inc trading resumes
TipRanks · 04/30 16:40
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
TipRanks · 04/30 16:35
Biotech Alert: Searches spiking for these stocks today
TipRanks · 04/28 16:30
Weekly Report: what happened at COEP last week (0421-0425)?
Weekly Report · 04/28 10:03
More
About COEP
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company. The Company is focused on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed by the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and robotic process automation capabilities. The Company’s subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.

Webull offers Coeptis Therapeutics Holdings Inc stock information, including NASDAQ: COEP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COEP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COEP stock methods without spending real money on the virtual paper trading platform.